LFMD Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
44.6M
-5.6%
47.3M
-5.7%
50.2M
+608.5%
7.1M
-85.2%
47.7M
Cost of Revenue
8.2M
+56.1%
5.3M
-10.8%
5.9M
+40.0%
4.2M
-40.1%
7.1M
Gross Profit
36.4M
-13.4%
42.0M
-5.1%
44.2M
+1453.3%
2.8M
-93.0%
40.7M
Operating Expenses
40.8M
-16.9%
49.1M
-7.6%
53.2M
+486.1%
9.1M
-79.3%
43.8M
R&D
1.9M
+5.1%
1.8M
-0.3%
1.8M
+295.2%
-920045
-149.9%
1.8M
SG&A
35.5M
-19.8%
44.3M
-1.7%
45.1M
+799.7%
5.0M
-87.2%
39.1M
Operating Income
-4466501
+37.4%
-7129601
+20.2%
-8929072
-43.5%
-6223260
-99.0%
-3126682
EBITDA
-7522067
-47.7%
-5091217
+26.6%
-6932845
+6.1%
-7386763
-24.0%
-5957436
Net Income
-4469713
+36.9%
-7083941
+20.2%
-8872596
-144.5%
19.9M
+647.9%
-3639964
EPS (Basic)
$-0.11
+31.3%
$-0.16
+20.0%
$-0.20
-148.8%
$0.41
+510.0%
$-0.10
EPS (Diluted)
$-0.11
+31.3%
$-0.16
+20.0%
$-0.20
-148.8%
$0.41
+510.0%
$-0.10
Shares (Diluted)
48.2M
+0.8%
47.8M
+1.0%
47.3M
+1.1%
46.8M
+1.4%
46.2M
LifeMD (LFMD) — Financials